首页 > 最新文献

World Psychiatry最新文献

英文 中文
Effects of cannabidiol on symptoms in people at clinical high risk for psychosis. 大麻二酚对精神病临床高危人群症状的影响。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21253
Sagnik Bhattacharyya,Elizabeth Appiah-Kusi,Robin Wilson,Aisling O'Neill,Michael Brammer,Steven Williams,Jesus Perez,Matthijs G Bossong,Philip McGuire
{"title":"Effects of cannabidiol on symptoms in people at clinical high risk for psychosis.","authors":"Sagnik Bhattacharyya,Elizabeth Appiah-Kusi,Robin Wilson,Aisling O'Neill,Michael Brammer,Steven Williams,Jesus Perez,Matthijs G Bossong,Philip McGuire","doi":"10.1002/wps.21253","DOIUrl":"https://doi.org/10.1002/wps.21253","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"22 1","pages":"451-452"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addictive disorders through the lens of the WPA Section on Addiction Psychiatry. 从 WPA成瘾精神病学分会的角度看成瘾性疾病。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21256
Hussien Elkholy,Roshan Bhad,Hamed Ekhtiari,Alexander M Baldacchino
{"title":"Addictive disorders through the lens of the WPA Section on Addiction Psychiatry.","authors":"Hussien Elkholy,Roshan Bhad,Hamed Ekhtiari,Alexander M Baldacchino","doi":"10.1002/wps.21256","DOIUrl":"https://doi.org/10.1002/wps.21256","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"35 1","pages":"459-460"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Shifting the pendulum - but with checks and balances. 钟摆移动--但有制衡。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21232
Tilman Steinert
{"title":"Shifting the pendulum - but with checks and balances.","authors":"Tilman Steinert","doi":"10.1002/wps.21232","DOIUrl":"https://doi.org/10.1002/wps.21232","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"48 1","pages":"388-389"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advance care planning: a multifaceted contributor to human rights-based care. 预先护理规划:对基于人权的护理的多方面贡献。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21234
Heather Zelle
{"title":"Advance care planning: a multifaceted contributor to human rights-based care.","authors":"Heather Zelle","doi":"10.1002/wps.21234","DOIUrl":"https://doi.org/10.1002/wps.21234","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"13 1","pages":"391-392"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The ICD-11 CDDR: benefits to health systems and clinical care. ICD-11 CDDR:对医疗系统和临床护理的益处。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21250
Oye Gureje
{"title":"The ICD-11 CDDR: benefits to health systems and clinical care.","authors":"Oye Gureje","doi":"10.1002/wps.21250","DOIUrl":"https://doi.org/10.1002/wps.21250","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"64 1","pages":"447-448"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancements, challenges and future horizons in personalized psychiatry. 个性化精神病学的进步、挑战和未来前景。
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21257
Giampaolo Perna,Daniela Caldirola,Alan F Schatzberg,Charles B Nemeroff
{"title":"Advancements, challenges and future horizons in personalized psychiatry.","authors":"Giampaolo Perna,Daniela Caldirola,Alan F Schatzberg,Charles B Nemeroff","doi":"10.1002/wps.21257","DOIUrl":"https://doi.org/10.1002/wps.21257","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"5 1","pages":"460-461"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physician-assisted dying in people with mental health conditions - whose choice? 精神疾病患者的医生协助死亡--谁的选择?
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1002/wps.21235
M E Jan Wise
{"title":"Physician-assisted dying in people with mental health conditions - whose choice?","authors":"M E Jan Wise","doi":"10.1002/wps.21235","DOIUrl":"https://doi.org/10.1002/wps.21235","url":null,"abstract":"","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"4 1","pages":"395-396"},"PeriodicalIF":73.3,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142246770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence, consciousness and psychiatry 人工智能、意识和精神病学
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-09-16 DOI: 10.1002/wps.21222
Giulio Tononi, Charles Raison
<p>In 1966, a researcher at the Massachusetts Institute of Technology introduced ELIZA, a computer program that simulated a psychotherapist in the Rogerian tradition, rephrasing a patient's words into questions according to simple but effective scripts. This was one of the first (and few) successes of early artificial intelligence (AI). To the dismay of its creator, some people took ELIZA for a real psychotherapist, perhaps because of our innate tendency to project consciousness when we detect intelligence, especially intelligent speech.</p><p>ELIZA's stuttering attempt at AI has now become an immensely eloquent golem. ChatGPT can easily outspeak, outwrite and outperform S. Freud. Because large language models (LLM) benefit from superhuman lexicon, knowledge, memory and speed, artificial brains can now trump natural ones in most tasks.</p><p>ELIZA was named after the flower-girl in G.B. Shaw's play Pygmalion, supposedly because it learned to improve its speech with practice. The original myth of Pygmalion – the sculptor who carved the ideal woman Galatea out of ivory and hoped to bring her to life – is even more apt: does the creation of AI portend artificial consciousness, perhaps even superhuman consciousness? Two camps are beginning to emerge, with radically different answers to this question.</p><p>According to the dominant computational/functionalist stance in cognitive neuroscience, the answer is yes<span><sup>1</sup></span>. Cognitive neuroscience assumes that we are ultimately machines running sophisticated software (that can derail and be reprogrammed). Neural algorithms recognize objects and scenes, direct attention, hold items in working memory, and store them in long-term memory. Complex neural computations drive cognitive control, decision making, emotional reactions, social behaviors, and of course language. In this view, consciousness must be just another function, perhaps the global broadcasting of information<span><sup>2</sup></span> or the metacognitive assessment of sensory inputs<span><sup>3</sup></span>. In this case, whenever computers can reproduce the same functions as our brain, just implemented differently (the functionalists’ “multiple realizability”), they will be conscious like we are.</p><p>Admittedly, despite LLMs sounding a lot like conscious humans nowadays, there is no principled way for determining whether they are already conscious and, if so, in which ways and to what degree<span><sup>1</sup></span>. Nor is it clear how we might establish whether they feel anything (just asking, we suspect, might not do…).</p><p>Cognitive neuroscience typically takes the <i>extrinsic perspective</i>, introduced by Galileo, which has been immensely successful in much of science. From this perspective, consciousness is either a “user illusion”<span><sup>4</sup></span>, or a mysterious “emergent” property. However, as recognized long ago by Leibniz, this leaves experience – what we see, hear, think and feel – entirely unacco
如果人工智能研究所的观点是正确的,那么与占主导地位的计算/功能主义观点形成鲜明对比的是,人工智能缺乏(而且将会缺乏)任何意识的火花:它可能比我们任何人都能说会道,甚至表现得更好(它将 "在功能上等同"),但它不会 "在现象上等同"(它将毫无感觉)5。 用纳格尔(T. Nagel)的话说,计算机无论多么智能,都不会有任何 "成为它的感觉"。就像小脑一样,计算机的意识架构也是错误的。即使它可以完美地执行我们可能关心的所有 "认知 "功能,包括那些我们习惯于认为是人类独有的功能,但所有这些功能都将在 "黑暗中 "展开。如果人工智能研究所是对的,那么将意识归因于人工智能就是一个真正的 "存在 "错误--因为意识是关于 "存在",而不是 "做",而人工智能是关于 "做",而不是 "存在"。在选择性压力下,生物制约因素可能会促进智能与意识的共同进化(通过偏爱高度整合的基质)9。 然而,在更大的背景下,智能与意识可以是双重分离的。我们可以在没有与智力相关的功能能力的情况下获得经验。例如,反应迟钝的病人可能什么也做不了,什么也说不出来,但却拥有丰富的主观体验8。没有意识也可能有高智慧:一个能言善辩的人工智能可能会与我们进行令人兴奋的对话,并以其智慧给我们留下深刻印象,但除了我们听到的句子流之外,并不存在任何其他东西--用 P. 拉金的话来说就是:"没有视觉,没有听觉/没有触觉、味觉或嗅觉,没有任何东西可以用来思考/没有任何东西可以用来爱或联系"。人工智能不仅对心理健康提出了独特而紧迫的挑战,也对人类的状况和我们在自然界中的地位提出了挑战。要么主流的计算/功能主义方法是正确的,我们--高度受限且经常有缺陷的生物机器--很快就会被硅制造的机器所取代,这些机器不仅更好更快,而且还能享受更丰富的内在生活。或者,IIT 是正确的,人类的每一种体验都是一种非凡而珍贵的现象,需要一种非常特殊的神经基质,而这种基质是无法通过模拟其功能来复制的。
{"title":"Artificial intelligence, consciousness and psychiatry","authors":"Giulio Tononi, Charles Raison","doi":"10.1002/wps.21222","DOIUrl":"https://doi.org/10.1002/wps.21222","url":null,"abstract":"&lt;p&gt;In 1966, a researcher at the Massachusetts Institute of Technology introduced ELIZA, a computer program that simulated a psychotherapist in the Rogerian tradition, rephrasing a patient's words into questions according to simple but effective scripts. This was one of the first (and few) successes of early artificial intelligence (AI). To the dismay of its creator, some people took ELIZA for a real psychotherapist, perhaps because of our innate tendency to project consciousness when we detect intelligence, especially intelligent speech.&lt;/p&gt;\u0000&lt;p&gt;ELIZA's stuttering attempt at AI has now become an immensely eloquent golem. ChatGPT can easily outspeak, outwrite and outperform S. Freud. Because large language models (LLM) benefit from superhuman lexicon, knowledge, memory and speed, artificial brains can now trump natural ones in most tasks.&lt;/p&gt;\u0000&lt;p&gt;ELIZA was named after the flower-girl in G.B. Shaw's play Pygmalion, supposedly because it learned to improve its speech with practice. The original myth of Pygmalion – the sculptor who carved the ideal woman Galatea out of ivory and hoped to bring her to life – is even more apt: does the creation of AI portend artificial consciousness, perhaps even superhuman consciousness? Two camps are beginning to emerge, with radically different answers to this question.&lt;/p&gt;\u0000&lt;p&gt;According to the dominant computational/functionalist stance in cognitive neuroscience, the answer is yes&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;. Cognitive neuroscience assumes that we are ultimately machines running sophisticated software (that can derail and be reprogrammed). Neural algorithms recognize objects and scenes, direct attention, hold items in working memory, and store them in long-term memory. Complex neural computations drive cognitive control, decision making, emotional reactions, social behaviors, and of course language. In this view, consciousness must be just another function, perhaps the global broadcasting of information&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; or the metacognitive assessment of sensory inputs&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;. In this case, whenever computers can reproduce the same functions as our brain, just implemented differently (the functionalists’ “multiple realizability”), they will be conscious like we are.&lt;/p&gt;\u0000&lt;p&gt;Admittedly, despite LLMs sounding a lot like conscious humans nowadays, there is no principled way for determining whether they are already conscious and, if so, in which ways and to what degree&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;. Nor is it clear how we might establish whether they feel anything (just asking, we suspect, might not do…).&lt;/p&gt;\u0000&lt;p&gt;Cognitive neuroscience typically takes the &lt;i&gt;extrinsic perspective&lt;/i&gt;, introduced by Galileo, which has been immensely successful in much of science. From this perspective, consciousness is either a “user illusion”&lt;span&gt;&lt;sup&gt;4&lt;/sup&gt;&lt;/span&gt;, or a mysterious “emergent” property. However, as recognized long ago by Leibniz, this leaves experience – what we see, hear, think and feel – entirely unacco","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"3 1","pages":""},"PeriodicalIF":73.3,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142248362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Where do neurodevelopmental conditions fit in transdiagnostic psychiatric frameworks? Incorporating a new neurodevelopmental spectrum 神经发育状况在跨诊断精神病学框架中的定位?纳入新的神经发育谱系
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-09-16 DOI: 10.1002/wps.21225
Giorgia Michelini, Christina O. Carlisi, Nicholas R. Eaton, Jed T. Elison, John D. Haltigan, Roman Kotov, Robert F. Krueger, Robert D. Latzman, James J. Li, Holly F. Levin-Aspenson, Giovanni A. Salum, Susan C. South, Kasey Stanton, Irwin D. Waldman, Sylia Wilson
Features of autism spectrum disorder, attention-deficit/hyperactivity disorder, learning disorders, intellectual disabilities, and communication and motor disorders usually emerge early in life and are associated with atypical neurodevelopment. These “neurodevelopmental conditions” are grouped together in the DSM-5 and ICD-11 to reflect their shared characteristics. Yet, reliance on categorical diagnoses poses significant challenges in both research and clinical settings (e.g., high co-occurrence, arbitrary diagnostic boundaries, high within-disorder heterogeneity). Taking a transdiagnostic dimensional approach provides a useful alternative for addressing these limitations, accounting for shared underpinnings across neurodevelopmental conditions, and characterizing their common co-occurrence and developmental continuity with other psychiatric conditions. Neurodevelopmental features have not been adequately considered in transdiagnostic psychiatric frameworks, although this would have fundamental implications for research and clinical practices. Growing evidence from studies on the structure of neurodevelopmental and other psychiatric conditions indicates that features of neurodevelopmental conditions cluster together, delineating a “neurodevelopmental spectrum” ranging from normative to impairing profiles. Studies on shared genetic underpinnings, overlapping cognitive and neural profiles, and similar developmental course and efficacy of support/treatment strategies indicate the validity of this neurodevelopmental spectrum. Further, characterizing this spectrum alongside other psychiatric dimensions has clinical utility, as it provides a fuller view of an individual's needs and strengths, and greater prognostic utility than diagnostic categories. Based on this compelling body of evidence, we argue that incorporating a new neurodevelopmental spectrum into transdiagnostic frameworks has considerable potential for transforming our understanding, classification, assessment, and clinical practices around neurodevelopmental and other psychiatric conditions.
自闭症谱系障碍、注意力缺陷/多动障碍、学习障碍、智力障碍以及交流和运动障碍的特征通常在生命早期出现,并与不典型的神经发育有关。DSM-5 和 ICD-11 将这些 "神经发育疾病 "归为一类,以反映它们的共同特征。然而,依赖于分类诊断在研究和临床环境中都会带来巨大的挑战(例如,高并发性、任意的诊断界限、疾病内部的高异质性)。采用跨诊断维度的方法为解决这些局限性、解释神经发育性疾病的共同基础以及描述其与其他精神疾病的共同发生和发展连续性提供了一个有用的替代方案。尽管神经发育特征对研究和临床实践有着根本性的影响,但在跨诊断的精神病学框架中,神经发育特征尚未得到充分考虑。对神经发育性疾病和其他精神疾病的结构进行研究后发现,越来越多的证据表明,神经发育性疾病的特征聚集在一起,形成了一个 "神经发育谱系",其范围从正常到受损都有。对共同的遗传基础、重叠的认知和神经特征、相似的发育过程和支持/治疗策略的有效性进行的研究表明,这一神经发育谱系是有效的。此外,将该谱系与其他精神病学维度一起描述具有临床实用性,因为它能更全面地反映个体的需求和优势,并且比诊断类别更具预后效用。基于这些令人信服的证据,我们认为,将新的神经发育谱纳入跨诊断框架,对于改变我们对神经发育性疾病和其他精神疾病的理解、分类、评估和临床实践具有相当大的潜力。
{"title":"Where do neurodevelopmental conditions fit in transdiagnostic psychiatric frameworks? Incorporating a new neurodevelopmental spectrum","authors":"Giorgia Michelini, Christina O. Carlisi, Nicholas R. Eaton, Jed T. Elison, John D. Haltigan, Roman Kotov, Robert F. Krueger, Robert D. Latzman, James J. Li, Holly F. Levin-Aspenson, Giovanni A. Salum, Susan C. South, Kasey Stanton, Irwin D. Waldman, Sylia Wilson","doi":"10.1002/wps.21225","DOIUrl":"https://doi.org/10.1002/wps.21225","url":null,"abstract":"Features of autism spectrum disorder, attention-deficit/hyperactivity disorder, learning disorders, intellectual disabilities, and communication and motor disorders usually emerge early in life and are associated with atypical neurodevelopment. These “neurodevelopmental conditions” are grouped together in the DSM-5 and ICD-11 to reflect their shared characteristics. Yet, reliance on categorical diagnoses poses significant challenges in both research and clinical settings (e.g., high co-occurrence, arbitrary diagnostic boundaries, high within-disorder heterogeneity). Taking a transdiagnostic dimensional approach provides a useful alternative for addressing these limitations, accounting for shared underpinnings across neurodevelopmental conditions, and characterizing their common co-occurrence and developmental continuity with other psychiatric conditions. Neurodevelopmental features have not been adequately considered in transdiagnostic psychiatric frameworks, although this would have fundamental implications for research and clinical practices. Growing evidence from studies on the structure of neurodevelopmental and other psychiatric conditions indicates that features of neurodevelopmental conditions cluster together, delineating a “neurodevelopmental spectrum” ranging from normative to impairing profiles. Studies on shared genetic underpinnings, overlapping cognitive and neural profiles, and similar developmental course and efficacy of support/treatment strategies indicate the validity of this neurodevelopmental spectrum. Further, characterizing this spectrum alongside other psychiatric dimensions has clinical utility, as it provides a fuller view of an individual's needs and strengths, and greater prognostic utility than diagnostic categories. Based on this compelling body of evidence, we argue that incorporating a new neurodevelopmental spectrum into transdiagnostic frameworks has considerable potential for transforming our understanding, classification, assessment, and clinical practices around neurodevelopmental and other psychiatric conditions.","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"36 1","pages":""},"PeriodicalIF":73.3,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142248369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aligning the “single law” proposal to the CRPD standard of “will and preferences” 使 "单一法律 "提案符合《残疾人权利公约》的 "意愿和偏好 "标准
IF 73.3 1区 医学 Q1 Medicine Pub Date : 2024-09-16 DOI: 10.1002/wps.21233
Jakov Gather, Matthé Scholten
<p>Galderisi et al<span><sup>1</sup></span> provide an excellent overview of the complex ethical challenges in psychiatry. We subscribe to the authors’ criticism of mental health laws employing a “disorder + risk” schema for involuntary intervention, and their conclusion that these laws discriminate against people with a mental health condition. The authors put forward instead a “single law” proposal in which “involuntary treatment would only be permitted when the objecting person has an impairment of decision-making ability – from any cause – and if treatment is in the person's best interests”<span><sup>1</sup></span>. We strongly endorse the core of this proposal, but would like to suggest three refinements to it.</p><p>First, we propose combining capacity assessment with supported decision-making, to ensure that no one is found to lack decision-making capacity before all reasonably available resources of supported decision-making have been exhausted. Second, we propose replacing the best interests standard by the substituted judgment standard, to achieve a closer alignment of substitute decisions with the will and preferences of the person concerned. Third, we suggest to explicitly define additional criteria for involuntary intervention, to avoid what we will call “the fallacious inference from substitute decision-making to coercion”. The proposed refinements are based on what we call the “combined supported decision-making model”, a model for the informed consent process that provides a non-discriminatory basis for decision-making about involuntary intervention<span><sup>2-5</sup></span>. In this commentary, we focus on the last two refinements.</p><p>Galderisi et al refer to a terminological distinction used in a judgment of the German Federal Constitutional Court to show that the “single law” proposal is consistent with the general principles of the United Nations (UN) Convention on the Rights of People with Disabilities (CRPD) and the wording of Article 12, particularly its insistence that “measures relating to the exercise of legal capacity respect the rights, will and preferences of the person”. The terminological distinction is between “free will” (<i>freier Wille</i>) and “natural will” (<i>natürlicher Wille</i>), which, according to the authors, maps on to the CRPD's distinction between “will” and “preferences”.</p><p>This terminological distinction plays an important role in the legal discourse around the German guardianship law (<i>Betreuungsrecht</i>), which is part of the German Civil Code and applies to all people who need support in managing their own affairs, regardless of whether they have a mental health condition<span><sup>6</sup></span>. The term “free will” (<i>freier Wille</i>) refers to the contemporaneous preferences of a person who possesses decision-making capacity regarding the decision at hand. Expressions of a person's free will must be respected by clinicians and have the status of consent or withdrawal of cons
加尔德里西等人1 对精神病学所面临的复杂伦理挑战进行了精彩的概述。我们赞同作者对采用 "障碍+风险 "模式进行非自愿干预的精神健康法律的批评,以及他们认为这些法律歧视精神疾病患者的结论。作者提出了一个 "单一法律 "的建议,即 "只有当反对者因任何原因导致决策能力受损,并且治疗符合其最大利益时,才允许非自愿治疗 "1 。首先,我们建议将能力评估与辅助决策结合起来,以确保在用尽所有可合理利用的辅助决策资源之前,不会发现任何人缺乏决策能力。第二,我们建议用替代判断标准取代最佳利益标准,使替代决定更符合当事人的意愿和偏好。第三,我们建议明确界定非自愿干预的附加标准,以避免我们称之为 "从替代决策到胁迫的谬误推论"。建议的改进措施是以我们所说的 "综合辅助决策模式 "为基础的,该模式是知情同 意程序的一种模式,它为非自愿干预的决策提供了一个非歧视性的基础2-5 。Galderisi 等人提到了德国联邦宪法法院在一份判决中使用的术语区别,以表明 "单一法律 "提案符合联合国《残疾人权利公约》(CRPD)的一般原则和第 12 条的措辞,特别是该条坚持 "与行使法律能力有关的措施应尊重个人的权利、意愿和偏好"。这种术语上的区别在围绕德国监护法(Betreuungsrecht)的法律讨论中发挥了重要作用,该法是德国民法典的一部分,适用于所有在管理自己事务方面需要帮助的人,无论他们是否有精神健康问题6。自由意志"(freier Wille)一词指的是具有决策能力的人对当前决定的当时选择。临床医生必须尊重一个人的自由意愿,并使其具有同意或撤回同意的地位;也就是说,自由意愿可以使原本不允许的干预行为变得允许,反之亦然。另一方面,"自然意愿"(natürlicher Wille)一词指的是缺乏决策能力的人对当前决定的当时偏好。在医疗决策过程中,必须仔细考虑一个人的自然意愿表达,但在某些情况下,基于其他考虑因素,也可以推翻其自然意愿表达,具体说明如下。它们相当于研究伦理文献中通常所说的 "同意 "和 "反对"。根据德国监护法,任何违背个人自然意愿的医疗干预(即个人不同意的任何医疗干预)都属于 "强制医疗"(ärztliche Zwangsmaßnahme),因此必须遵守严格的条件。尽管作者明确指出,最佳利益标准应根据当事人的信仰和价值观进行主观解释,但我们担心在临床实践中仍会对其进行客观理解。最佳利益标准最初源于家长式的 "医生知道什么是最好的 "方法,而且--尽管作者小心翼翼地进行了限定--临床医生可能会根据 Hawkins7 所称的 "福利医疗主义 "来理解最佳利益标准,即临床医生始终认为,符合当事人最佳利益的做法就是在当事人的情况下具有医学意义的做法。为了避免这种潜在的误解,我们建议用替代判断标准取代最佳利益标准。后一种标准将当事人的意愿和偏好置于中心位置:它将做出当事人如果有决策能力时会做出的治疗决定的任务分配给替代决策者8。
{"title":"Aligning the “single law” proposal to the CRPD standard of “will and preferences”","authors":"Jakov Gather, Matthé Scholten","doi":"10.1002/wps.21233","DOIUrl":"https://doi.org/10.1002/wps.21233","url":null,"abstract":"&lt;p&gt;Galderisi et al&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; provide an excellent overview of the complex ethical challenges in psychiatry. We subscribe to the authors’ criticism of mental health laws employing a “disorder + risk” schema for involuntary intervention, and their conclusion that these laws discriminate against people with a mental health condition. The authors put forward instead a “single law” proposal in which “involuntary treatment would only be permitted when the objecting person has an impairment of decision-making ability – from any cause – and if treatment is in the person's best interests”&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;. We strongly endorse the core of this proposal, but would like to suggest three refinements to it.&lt;/p&gt;\u0000&lt;p&gt;First, we propose combining capacity assessment with supported decision-making, to ensure that no one is found to lack decision-making capacity before all reasonably available resources of supported decision-making have been exhausted. Second, we propose replacing the best interests standard by the substituted judgment standard, to achieve a closer alignment of substitute decisions with the will and preferences of the person concerned. Third, we suggest to explicitly define additional criteria for involuntary intervention, to avoid what we will call “the fallacious inference from substitute decision-making to coercion”. The proposed refinements are based on what we call the “combined supported decision-making model”, a model for the informed consent process that provides a non-discriminatory basis for decision-making about involuntary intervention&lt;span&gt;&lt;sup&gt;2-5&lt;/sup&gt;&lt;/span&gt;. In this commentary, we focus on the last two refinements.&lt;/p&gt;\u0000&lt;p&gt;Galderisi et al refer to a terminological distinction used in a judgment of the German Federal Constitutional Court to show that the “single law” proposal is consistent with the general principles of the United Nations (UN) Convention on the Rights of People with Disabilities (CRPD) and the wording of Article 12, particularly its insistence that “measures relating to the exercise of legal capacity respect the rights, will and preferences of the person”. The terminological distinction is between “free will” (&lt;i&gt;freier Wille&lt;/i&gt;) and “natural will” (&lt;i&gt;natürlicher Wille&lt;/i&gt;), which, according to the authors, maps on to the CRPD's distinction between “will” and “preferences”.&lt;/p&gt;\u0000&lt;p&gt;This terminological distinction plays an important role in the legal discourse around the German guardianship law (&lt;i&gt;Betreuungsrecht&lt;/i&gt;), which is part of the German Civil Code and applies to all people who need support in managing their own affairs, regardless of whether they have a mental health condition&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt;. The term “free will” (&lt;i&gt;freier Wille&lt;/i&gt;) refers to the contemporaneous preferences of a person who possesses decision-making capacity regarding the decision at hand. Expressions of a person's free will must be respected by clinicians and have the status of consent or withdrawal of cons","PeriodicalId":23858,"journal":{"name":"World Psychiatry","volume":"237 1","pages":""},"PeriodicalIF":73.3,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142248367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Psychiatry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1